InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,717.60
(
0.20%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.72
(
0.40%
)
Bitcoin
62,765.64
(
2.14%
)
Post# of 112996
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

2morrowsGains

Send PM Follow Ignore
Followers 77
Posts 7201
Boards Moderated 0
Alias Born 01/16/2005

2morrowsGains

Member Level

Re: John Bates post# 65921

Thursday, 11/07/2019 2:23:47 PM

Thursday, November 07, 2019 2:23:47 PM

Post# of 112996
SRTS...More growing pains...Sales came in short again...And they had tariff issues so no sales to China for the quarter. They are trying to lock in a contract with SkinCure. And they are still hoping to get three more Sculptra units shipped by year-end.
On a brighter note, these guys are great with their cash. Low cash burn, and no debt.
Sensus just received clearance from Korea and they are working on getting clearance in Brazil and India.
The stock got hammered today. My holdings are not as large as they once were, but I still like the company and I think there's huge growth over the next few years. Trading at $4 and dipped into the $3's today. It'll come back.


The information posted by 2morrowsGains is opinion only and should not to be taken as investment advice.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up